Insider transactions

EDGAR

Myomo, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
10 transactions, 505,740 shares
Sum of shares × price per share: 435,648.1466
Open-market sales (code S)
8 transactions, 203,313 shares
Sum of shares × price per share: 231,123.302

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 54

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-13 Filed 2026-10-15GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)71,2500—1,514,292Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under the Company's 2018 Stock Option and Incentive Plan. The RSU's vest in three equal annual installments beginning on June 9, 2027.
Open filing 0001193125-26-422913 Read from the filing’s XML Dispute this row
2026-10-13 Filed 2026-10-15HENRY DAVID A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)51,2500—549,862Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under the Company's 2018 Stock Option and Incentive Plan. The RSU's vest in three equal annual installments beginning June 9, 2027.
Open filing 0001193125-26-422923 Read from the filing’s XML Dispute this row
2026-10-13 Filed 2026-10-15Kovelman Harry Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)32,5000—122,389Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs) under the Company's 2018 Stock Option and Incentive Plan. The RSUs vest in three equal annual installments beginning on June 9, 2027.
Open filing 0001193125-26-422937 Read from the filing’s XML Dispute this row
2026-10-12 Filed 2026-10-13McClure Mary-Katherine Hale Officer: Chief Commericial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)275,0000—275,000Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under an inducement grant approved by the Compensation Committee of the Board of Directors in reliance of an exception granted under Section 711 of the NYSE Amercian Company Guide. 100,000 of these RSU's shall vest on the six-month anniversary of the grant date, 25,000 shall vest on the one year anniversary of the grant date, 125,000 shall vest on the second anniversary of the grant date and the remainder on the third anniversary of the grant date.
Open filing 0001193125-26-419757 Read from the filing’s XML Dispute this row
2026-10-12 Filed 2026-10-13HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,1331.37
4,292.21

Derived: shares × price per share. Exact value 4292.21.

498,612Direct (D) No
F2
  • F2 Represents shares sold on October 12, 2026 solely to pay income and other taxes associated with the vesting of RSU's on October 8, 2026, pursuant to an irrevocable election made by the Reporting Party on December 11, 2025
Open filing 0001193125-26-420694 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,3630—1,443,042Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on January 9, 2027
Open filing 0001193125-26-420689 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13HENRY DAVID A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,2720—501,745Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on January 9, 2027
Open filing 0001193125-26-420694 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-10-15Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,8441.2709
20,136.1396

Derived: shares × price per share. Exact value 20136.1396.

89,889Direct (D) No
F1
  • F1 Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-422930 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-14Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,4881.2709
19,683.6992

Derived: shares × price per share. Exact value 19683.6992.

90,245Direct (D) No
F1
  • F1 Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-390646 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Morris Milton Mayo Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,0001.41
21,150

Derived: shares × price per share. Exact value 21150.00.

208,391Direct (D) No
F1
  • F1 Sale transaction was completed in a single lot.
Open filing 0001193125-26-383718 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,5001.7331
30,329.25

Derived: shares × price per share. Exact value 30329.2500.

105,733Direct (D) No
F1
  • F1 Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-361870 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-21Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,2501.7331
29,895.975

Derived: shares × price per share. Exact value 29895.9750.

105,983Direct (D) No
F1
  • F1 Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-361391 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11HENRY DAVID A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)68,6440—495,473Direct (D) No
F1
  • F1 Represents a grant of fully vested Restricted Stock Units (RSU's) as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025.
Open filing 0001193125-26-343460 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)25,3101.42
35,940.2

Derived: shares × price per share. Exact value 35940.20.

470,163Direct (D) No
F2
  • F2 Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026.
Open filing 0001193125-26-343460 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)146,9090—1,434,679Direct (D) No
F1
  • F1 Represents a grant of fully vested Restricted Stock Units (RSU's) as payment for the incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025.
Open filing 0001193125-26-343465 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11Mitchell Micah Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)58,4090—152,297Direct (D) No
F1
  • F1 Represents a grant of fully vested Restricted Stock Units (RSU's) as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025.
Open filing 0001193125-26-343470 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11Mitchell Micah Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)21,5591.42
30,613.78

Derived: shares × price per share. Exact value 30613.78.

130,738Direct (D) No
F2
  • F2 Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026.
Open filing 0001193125-26-343470 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11Kovelman Harry Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)55,1490—145,690Direct (D) No
F1
  • F1 Represents a grant of fully vested Restricted Stock Units (RSU's) as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025.
Open filing 0001193125-26-343483 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11Kovelman Harry Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)22,4571.42
31,888.94

Derived: shares × price per share. Exact value 31888.94.

123,233Direct (D) No
F2
  • F2 Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026.
Open filing 0001193125-26-343483 Read from the filing’s XML Dispute this row
2026-07-13 Filed 2026-07-13HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,1661.09
5,630.94

Derived: shares × price per share. Exact value 5630.94.

426,829Direct (D) No
F2
  • F2 Represents shares sold on July 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on July 10, 2026. Transaction was completed pursuant to an irrevocable election made by the Reporting Person on December 11, 2025.
Open filing 0001193125-26-302089 Read from the filing’s XML Dispute this row
2026-07-10 Filed 2026-07-13HENRY DAVID A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,8400—431,995Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026.
Open filing 0001193125-26-302089 Read from the filing’s XML Dispute this row
2026-07-10 Filed 2026-07-13GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,4540—1,287,770Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026.
Open filing 0001193125-26-302072 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26KIRK THOMAS F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—772,569Direct (D) No
F1
  • F1 Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026.
Open filing 0001193125-26-285703 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26Crowley Thomas Aloysius Jr. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—154,452Direct (D) No
F1
  • F1 Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026.
Open filing 0001193125-26-285705 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26Morris Milton Mayo Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—223,391Direct (D) No
F1
  • F1 Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control.
Open filing 0001193125-26-285681 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26FEBBO WILLIAM J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—123,704Direct (D) No
F1
  • F1 Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026.
Open filing 0001193125-26-285686 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26Getz Heather C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—210,458Direct (D) No
F1
  • F1 Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control.
Open filing 0001193125-26-285696 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-26Manko Joseph M. Jr. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)78,7040—78,704Direct (D) No
F1
  • F1 The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control.
Open filing 0001664091-26-000003 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-12Kovelman Harry Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,4421.20
12,530.4

Derived: shares × price per share. Exact value 12530.40.

90,541Direct (D) No
F1
  • F1 Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026.
Open filing 0001193125-26-269675 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-12Mitchell Micah Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9,0611.20
10,873.2

Derived: shares × price per share. Exact value 10873.20.

93,888Direct (D) No
F1
  • F1 Represents sale of common stock on June 12, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 11, 2026 pursuant to an irrevocable election made on May 28, 2026.
Open filing 0001193125-26-269642 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-12HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,9690—424,155Direct (D) No
F1
  • F1 Represents shares withheld on June 12, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 11, 2026.
Open filing 0001193125-26-269607 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-09HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,0500—435,124Direct (D) No
F1
  • F1 Represents shares withheld on June 8, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 5, 2026.
Open filing 0001193125-26-263742 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-09Mitchell Micah Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)6,5291.33
8,683.57

Derived: shares × price per share. Exact value 8683.57.

102,949Direct (D) No
F1
  • F1 Represents sale of common stock on June 8, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 5, 2026 pursuant to an irrevocable election made on May 28, 2026.
Open filing 0001193125-26-263916 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-09Kovelman Harry Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7,6351.33
10,154.55

Derived: shares × price per share. Exact value 10154.55.

100,983Direct (D) No
F1
  • F1 Represents shares sold on June 8, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 5, 2026.
Open filing 0001193125-26-263886 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-09KIRK THOMAS F Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)40,0021.27
50,802.54

Derived: shares × price per share. Exact value 50802.54.

693,865Direct (D) No
F1, F2
  • F1 Represents open market purchases.
  • F2 Represented weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $1.23 to $1.30 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request.
Open filing 0001193125-26-263732 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01KIRK THOMAS F Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)25,0000.993
24,825

Derived: shares × price per share. Exact value 24825.000.

653,863Direct (D) No
F1, F2
  • F1 Represents open market purchases.
  • F2 Shares were purchased in multiple lots at this purchase price per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request.
Open filing 0001193125-26-249844 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-05-28Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,5361.0172
11,734.4192

Derived: shares × price per share. Exact value 11734.4192.

108,618Direct (D) No
F1, F3
  • F1 Represents open market sale of shares.
  • F3 Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.035 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-245953 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Kovelman Harry Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)20,4641.002
20,504.928

Derived: shares × price per share. Exact value 20504.928.

120,154Direct (D) No
F1, F2
  • F1 Represents open market sale of shares.
  • F2 Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.005 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-245953 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-18KIRK THOMAS F Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)43,4010.91
39,494.91

Derived: shares × price per share. Exact value 39494.91.

628,863Direct (D) No
F1, F3
  • F1 Represents open market purchases.
  • F3 Represents weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $0.815 to $0.91 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request.
Open filing 0001193125-26-229323 Read from the filing’s XML Dispute this row
2026-05-15 Filed 2026-05-18KIRK THOMAS F Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)31,6050.9096
28,747.908

Derived: shares × price per share. Exact value 28747.9080.

585,462Direct (D) No
F1, F2
  • F1 Represents open market purchases.
  • F2 Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.9041 to $0.91 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-229323 Read from the filing’s XML Dispute this row
2026-05-15 Filed 2026-05-18Manko Joseph M. Jr. Director
P

Open market or private purchase of non-derivative or derivative security

MYO
Acquired (A)30,3670.8878
26,959.8226

Derived: shares × price per share. Exact value 26959.8226.

2,309,775Indirect (I) By Horton Capital Partners Fund, LP (1)No— Open filing 0001664091-26-000002 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-06-08Mitchell Micah Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)90,2310.861
77,688.891

Derived: shares × price per share. Exact value 77688.891.

109,478Direct (D) No
F1, F2
  • F1 Represents sale of common stock on May 14, 2026 in a series of open market transactions.
  • F2 Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $0.85 to $0.889 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-261825 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-05-18Manko Joseph M. Jr. Director
P

Open market or private purchase of non-derivative or derivative security

MYO
Acquired (A)170,8300.8602
146,947.966

Derived: shares × price per share. Exact value 146947.9660.

2,279,408Indirect (I) By Horton Capital Partners Fund, LP (1)No— Open filing 0001664091-26-000002 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-16FEBBO WILLIAM J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)45,0000—45,000Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's vest in their entirety on the first anniversary of the grant date.
Open filing 0001193125-26-159101 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-14HENRY DAVID A Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,9530.71
2,806.63

Derived: shares × price per share. Exact value 2806.63.

445,174Direct (D) No
F2
  • F2 Represents shares sold on April 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on April 12, 2026. Transaction was conpleted pursuant to an irrevocable election made by the Reporting Party on December 11, 2025.
Open filing 0001193125-26-155337 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-14GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)19,3950—1,280,045Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026.
Open filing 0001193125-26-155308 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-14HENRY DAVID A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,5000—449,127Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026.
Open filing 0001193125-26-155337 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-14GUDONIS PAUL R Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)16,6660—1,277,316Direct (D) No
F1
  • F1 Represents a grant of Restricted Stock Units (RSU's) under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026.
Open filing 0001193125-26-155349 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-17Getz Heather C Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.6986
13,972

Derived: shares × price per share. Exact value 13972.0000.

131,754Direct (D) No
F1
  • F1 Represents open market purchase in a single transaction.
Open filing 0001193125-26-111290 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-16KIRK THOMAS F Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)72,0000.7099
51,112.8

Derived: shares × price per share. Exact value 51112.8000.

553,857Direct (D) No
F1, F2
  • F1 Represents open market purchases.
  • F2 Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.70 to $0.71 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request.
Open filing 0001193125-26-108732 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 71

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Rosalind Advisors, Inc. 3,917,886 SH6,111,902 dollarsHigher by 280,000 Prior quarter: 3,637,886Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 1,636,570 SH2,553,049 dollarsUnchanged Prior quarter: 1,636,570Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Clearstead Advisors, LLC Partly reported under another manager425,600 SH663,936 dollarsLower by 9 Prior quarter: 425,609Open filing 0000842775-26-000005 Filed 2026-11-06 Dispute this row
TWO SIGMA INVESTMENTS, LP 388,107 SH605,447 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager380,802 SH594,051 dollarsLower by 215,550 Prior quarter: 596,352Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager350,490 SH546,939 dollarsHigher by 6,073 Prior quarter: 344,417Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MORGAN STANLEY Partly reported under another manager330,944 SH516,272 dollarsHigher by 324,320 Prior quarter: 6,624Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Palumbo Wealth Management LLC 278,354 SH434,233 dollarsLower by 21,422 Prior quarter: 299,776Open filing 0001951757-26-001936 Filed 2026-11-13 Dispute this row
GSA CAPITAL PARTNERS LLP 252,663 SH394 dollarsLower by 19,213 Prior quarter: 271,876Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 247,380 SH385,913 dollarsLower by 23,914 Prior quarter: 271,294Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 246,139 SH383,977 dollarsHigher by 38,462 Prior quarter: 207,677Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager222,755 SH347,498 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager207,782 SH324,140 dollarsLower by 720,486 Prior quarter: 928,268Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager180,629 SH281,781 dollarsNot in the prior quarter’s filings read Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
LPL Financial LLC 153,100 SH238,836 dollarsLower by 154,900 Prior quarter: 308,000Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
BlackRock, Inc. Partly reported under another manager136,261 SH212,567 dollarsLower by 86,956 Prior quarter: 223,217Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager109,786 SH171,266 dollarsHigher by 7,268 Prior quarter: 102,518Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Centiva Capital, LP 108,606 SH169,425 dollarsHigher by 22,610 Prior quarter: 85,996Open filing 0001172661-26-005016 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager105,875 SH165,165 dollarsUnchanged Prior quarter: 105,875Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager101,700 SH158,652 dollarsHigher by 53,200 Prior quarter: 48,500Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager80,609 SH125,750 dollarsUnchanged Prior quarter: 80,609Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager78,300 SH122,148 dollarsLower by 6,700 Prior quarter: 85,000Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager74,392 SH115 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
XTX Topco Ltd Partly reported under another manager68,600 SH107,016 dollarsLower by 41,428 Prior quarter: 110,028Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
Stratos Wealth Partners, LTD. 60,000 SH93,600 dollarsUnchanged Prior quarter: 60,000Open filing 0001612865-26-000006 Filed 2026-11-13 Dispute this row
Quadrature Capital Ltd Partly reported under another manager57,956 SH90,411 dollarsNot in the prior quarter’s filings read Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager56,830 SH88,655 dollarsLower by 38,018 Prior quarter: 94,848Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Call 51,400 SH80,184 dollarsLower by 40,900 Prior quarter: 92,300Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,519 SH66,330 dollarsNot in the prior quarter’s filings read Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
Empowered Funds, LLC Partly reported under another manager39,619 SH61,806 dollarsNot in the prior quarter’s filings read Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
Accel Wealth Management Partly reported under another manager39,082 SH60,968 dollarsUnchanged Prior quarter: 39,082Open filing 0001838226-26-000006 Filed 2026-10-13 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager34,800 SH54,288 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager28,638 SH44,675 dollarsLower by 971 Prior quarter: 29,609Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
IMC-Chicago, LLC 26,328 SH41,072 dollarsHigher by 5,854 Prior quarter: 20,474Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
Summit Financial Strategies, Inc. 25,000 SH39,000 dollarsUnchanged Prior quarter: 25,000Open filing 0001172661-26-004530 Filed 2026-10-14 Dispute this row
Accurate Wealth Management, LLC 21,120 SH27,245 dollarsUnchanged Prior quarter: 21,120Open filing 0001754960-26-000918 Filed 2026-10-20 Dispute this row
Cerity Partners LLC 19,418 SH30,292 dollarsLower by 25,880 Prior quarter: 45,298Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
IEQ CAPITAL, LLC 16,725 SH26,091 dollarsLower by 111,024 Prior quarter: 127,749Open filing 0001779789-26-000005 Filed 2026-11-10 Dispute this row
Qube Research Technologies Ltd 14,202 SH22,155 dollarsLower by 53,562 Prior quarter: 67,764Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
IMC-Chicago, LLC Option: Call 13,600 SH21,216 dollarsNot in the prior quarter’s filings read Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
Abel Hall, LLC Partly reported under another manager12,927 SH20,166 dollarsLower by 337 Prior quarter: 13,264Open filing 0002013339-26-000005 Filed 2026-10-19 Dispute this row
StoneX Group Inc. Partly reported under another manager11,842 SH11,960 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager11,400 SH17,784 dollarsNot in the prior quarter’s filings read Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
Vanguard Global Advisers, LLC 10,870 SH16,957 dollarsUnchanged Prior quarter: 10,870Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager9,888 SH15,524 dollarsLower by 18,842 Prior quarter: 28,730Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager7,090 SH11,060 dollarsLower by 406,589 Prior quarter: 413,679Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Arax Advisory Partners Partly reported under another manager5,710 SH8,908 dollarsLower by 10,884 Prior quarter: 16,594Open filing 0001586767-26-000009 Filed 2026-11-12 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager5,045 SH7,870 dollarsHigher by 45 Prior quarter: 5,000Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager4,575 SH7,000 dollarsLower by 3,601 Prior quarter: 8,176Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
NISA INVESTMENT ADVISORS, LLC 4,218 SH6,580 dollarsUnchanged Prior quarter: 4,218Open filing 0000937615-26-000007 Filed 2026-10-20 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Jefferies Financial Group Inc. 704,275 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 120,791 SH
  • Virtu Financial LLC 84,104 SH
  • HRT FINANCIAL LP 83,049 SH
  • Mariner, LLC 40,911 SH
  • Ground Swell Capital, LLC 34,874 SH
  • BANK OF AMERICA CORP /DE/ 30,397 SH
  • WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 30,389 SH
  • HSBC HOLDINGS PLC 29,235 SH
  • MERCER GLOBAL ADVISORS INC /ADV 24,339 SH
  • Point72 Asset Management, L.P. 19,912 SH
  • CAPTRUST FINANCIAL ADVISORS 18,533 SH
  • Creative Planning 18,010 SH
  • DGS Capital Management, LLC 14,294 SH
  • Pallas Capital Advisors LLC 12,308 SH
  • BRIGHTON JONES LLC 11,789 SH
  • Tower Research Capital LLC (TRC) 6,753 SH
  • Rockefeller Capital Management L.P. 4,500 SH
  • BARCLAYS PLC 3,824 SH
  • Integrated Wealth Concepts LLC 3,710 SH
  • CITIGROUP INC 1,037 SH
  • Fortitude Family Office, LLC 116 SH
  • SJS Investment Consulting Inc. 57 SH
  • Transamerica Financial Advisors, LLC 50 SH
  • JPL Wealth Management, LLC 10 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Rosalind Advisors, Inc. Common Shares9.97,681,144.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 13Open filing 0001622627-26-000028 Dispute this row
SALAMON STEVEN A J Common Shares9.97,681,144.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 13Open filing 0001622627-26-000028 Dispute this row
Aharon Gil Common Shares9.97,681,144.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 13Open filing 0001622627-26-000028 Dispute this row
Rosalind Master Fund L.P. Common Shares9.97,681,144.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 13Open filing 0001622627-26-000028 Dispute this row
Rosalind Advisors, Inc. Common Shares9.97,401,144.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 12Open filing 0001622627-26-000016 Dispute this row
SALAMON STEVEN A J Common Shares9.97,401,144.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 12Open filing 0001622627-26-000016 Dispute this row
Aharon Gil Common Shares9.97,401,144.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 12Open filing 0001622627-26-000016 Dispute this row
Rosalind Master Fund L.P. Common Shares9.97,401,144.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 12Open filing 0001622627-26-000016 Dispute this row
Horton Capital Partners Fund, LP Common Stock, Par Value $0.0001 Per Share6.02,309,775.0005/09/2026 Filed 2026-05-18SCHEDULE 13D/AAmendment 1Open filing 0001161697-26-000118 Dispute this row
Horton Capital Partners, LLC Common Stock, Par Value $0.0001 Per Share6.02,309,775.0005/09/2026 Filed 2026-05-18SCHEDULE 13D/AAmendment 1Open filing 0001161697-26-000118 Dispute this row
Horton Capital Management, LLC Common Stock, Par Value $0.0001 Per Share6.02,309,775.0005/09/2026 Filed 2026-05-18SCHEDULE 13D/AAmendment 1Open filing 0001161697-26-000118 Dispute this row
Joseph M. Manko, Jr. Common Stock, Par Value $0.0001 Per Share6.02,309,775.0005/09/2026 Filed 2026-05-18SCHEDULE 13D/AAmendment 1Open filing 0001161697-26-000118 Dispute this row
Rosalind Advisors, Inc. Common Shares9.97,603,030.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 11Open filing 0001622627-26-000003 Dispute this row
SALAMON STEVEN A J Common Shares9.97,603,030.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 11Open filing 0001622627-26-000003 Dispute this row
Aharon Gil Common Shares9.97,603,030.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 11Open filing 0001622627-26-000003 Dispute this row
Rosalind Master Fund L.P. Common Shares9.97,603,030.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 11Open filing 0001622627-26-000003 Dispute this row
Horton Capital Partners Fund, LP Common Stock, Par Value $0.0001 Per Share5.11,960,212.0012/24/2025 Filed 2025-12-29SCHEDULE 13DOpen filing 0001161697-25-000476 Dispute this row
Horton Capital Partners, LLC Common Stock, Par Value $0.0001 Per Share5.11,960,212.0012/24/2025 Filed 2025-12-29SCHEDULE 13DOpen filing 0001161697-25-000476 Dispute this row
Horton Capital Management, LLC Common Stock, Par Value $0.0001 Per Share5.11,960,212.0012/24/2025 Filed 2025-12-29SCHEDULE 13DOpen filing 0001161697-25-000476 Dispute this row
Joseph M. Manko, Jr. Common Stock, Par Value $0.0001 Per Share5.11,960,212.0012/24/2025 Filed 2025-12-29SCHEDULE 13DOpen filing 0001161697-25-000476 Dispute this row
Rosalind Advisors, Inc. Common Shares9.97,554,046.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 10Open filing 0001622627-25-000033 Dispute this row
SALAMON STEVEN A J Common Shares9.97,554,046.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 10Open filing 0001622627-25-000033 Dispute this row
Aharon Gil Common Shares9.97,554,046.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 10Open filing 0001622627-25-000033 Dispute this row
Rosalind Master Fund L.P. Common Shares9.97,554,046.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 10Open filing 0001622627-25-000033 Dispute this row
Orin Hirschman Common Stock, $0.0001 par value per share1.3523,000.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 4Open filing 0001493152-25-021433 Dispute this row
AIGH Capital Management LLC Common Stock, $0.0001 par value per share00.0009/30/2025 Filed 2025-11-10SCHEDULE 13G/AAmendment 4Open filing 0001493152-25-021433 Dispute this row
Rosalind Advisors, Inc. Common Shares9.97,359,046.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 9Open filing 0001579206-25-000009 Dispute this row
SALAMON STEVEN A J Common Shares9.97,359,046.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 9Open filing 0001579206-25-000009 Dispute this row
Aharon Gil Common Shares9.97,359,046.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 9Open filing 0001579206-25-000009 Dispute this row
Rosalind Master Fund L.P. Common Shares9.97,359,046.0006/30/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 9Open filing 0001579206-25-000009 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,687,210 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Myomo, Inc.